Sage Therapeutics’ Zuranolone Is A Lost Cause In Depression Market (NASDAQ:SAGE)

Sad unhappy teenage girl



Sage Therapeutics (NASDAQ:SAGE) is a biopharmaceutical company with a specialization in brain health medications. They focus on treating disorders such as depression, neurology, and neuropsychiatry by targeting the central nervous system’s GABA and NMDA receptor systems. With products like Zulresso (intravenous brexanolone) for

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *